E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for Almirall SA > News item
Published on 11/2/2015 in the Prospect News High Yield Daily and Prospect News Liability Management Daily.

Almirall starts asset sale offer for €325 million of 4 5/8% notes

New York, Nov. 2 – Almirall, SA announced an asset sale offer to buy all €325 million of its 4 5/8% senior notes due 2021.

The company is offering to pay par plus accrued interest, according to a notice from the company.

The offer ends at 10 a.m. ET on Dec. 1. Settlement is scheduled for Dec. 4.

Almirall is a Barcelona, Spain-based pharmaceutical firm.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.